US Patent Issued to SMT BIO on June 16 for "Composition for preventing or treating extrahepatic bile duct cancer" (South Korean Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,889, issued on June 16, was assigned to SMT BIO Co. LTD. (Seoul, South Korea).

"Composition for preventing or treating extrahepatic bile duct cancer" was invented by Yong-Yoon Chung (Seoul, South Korea), Jung-Min Im (Gwangmyeong-si, South Korea) and In-Hye Jung (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for preventing or treating extrahepatic bile duct cancer containing, as active ingredients, natural killer (NK) cells and an anti-PD-1 antibody."

The patent was filed on Jan. 13, 2022, under Application No. 17/917,854.

*For further information, including images, c...